Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">CMV alphavaccine: Phase I started</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

AlphaVax started a double-blind, placebo-controlled Phase I trial in 40 healthy volunteers. ......

CMV alphavaccine: Phase I started

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery: Disruptive Innovation

Distillery

Hot Topics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

Bio€quity Europe

BioCentury Grand Rounds 2024

BioCentury Grand Rounds

The BioCentury-BayHelix China Healthcare Summit

BioCentury-BayHelix China Healthcare Summit

The BioCentury Show

Webinars - Upcoming & On-Demand

Events

My Workspace

Company Overview

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Trial

Request a Subscription

Advertising - Sponsorship Inquiry

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Contact

Home